KRAS and colorectal carcinoma: HLA LOH occurred in samples with recurrent mutations of S–C changing pattern, including KRAS, SYNE1, FBXL2, DNAH11, and CACNA1H, indicating that this mutational clonal pattern promotes CRC cells evading the immune system during liver metastasis [50].